Oxybutinin Other names: Oxybutynin Oxybutynin hydrochloride

Chemical formula: C₂₂H₃₁NO₃  Molecular mass: 357.486 g/mol  PubChem compound: 4634

Therapeutic indications

Oxybutinin is indicated for:

Urge incontinence, increased urinary frequency

Population group: only adults (18 years old or older)

Symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency as may occur in adult patients with unstable bladder.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Urge incontinence, increased urinary frequency

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old)

Symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency as may occur in adult patients with unstable bladder.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Oxybutinin is contraindicated in the following cases:

Lactation

Lactation

Narrow-angle glaucoma, shallow anterior chamber

at least one of
Angle-closure glaucoma
Shallow anterior chamber of eye

Myasthenia gravis

Myasthenia gravis

Urinary retention

Retention of urine

Gastrointestinal obstructive disorder, paralytic ileus, intestinal atony

at least one of
Gastrointestinal obstruction
Paralytic ileus
Atony of colon

Severe ulcerative colitis

Colitis gravis

Toxic megacolon

† Toxic megacolon

Urinary frequency and nocturia due to heart or renal failure

at least one of
Increased frequency of urination
Nocturia
and additionally at least one of
Cardiac failure
Renal failure

Porphyria

Porphyria

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Structured Product Labeling (SPL/PLR) 2017: OXYTROL Transdermal system
Summary of Product Characteristics (SPC) 2021: KENTERA Transdermal patch
Summary of Product Characteristics (SPC) 2019: LYRINEL XL Prolonged release tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈